Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Raymond James Downgrades Invitae to Market Perform

Raymond James Downgrades Invitae to Market Perform

Raymond James analyst Andrew Cooper downgrades Invitae (NYSE:NVTA) from Outperform to Market Perform.

byBenzinga Newsdesk

July 21, 2022

1 minute read

Raymond James analyst Andrew Cooper downgrades Invitae (NYSE:NVTA) from Outperform to Market Perform.

Arvinas Releases Early Cut Data Showing Encouraging Efficacy In Prostate Cancer With Certain Mutations

By Vandana Singh

June 8, 11:05 AM

Arvinas Inc (NASDAQ: ARVN) announced interim data from its Phase 1/2 dose escalation and expansion trial of ARV-766 in metastatic

ARVN

Equinor’s Massive Gas Pact: Long-Term Deal With Germany’s SEFE, Plus Hydrogen Partnership

By Lekha Gupta

December 19, 9:41 AM

Equinor ASA (NYSE: EQNR) penned a long-term gas sales

EQNR

Hess Midstream LP Announces Pricing Of $288M Secondary Public Offering Of 10M Class A Shares At A Price Of $28.80/Share

By Happy Mohamed

August 16, 12:19 AM

Hess Midstream LP (NYSE:HESM) ("HESM") today announced the pricing of an underwritten public offering of an aggregate 10,000,000 Class A shares representing limited partner interests in HESM by an affiliate of

HESM

Axcella Therapeutics Puts Development Of NASH Program Aside, Reduces Workforce By 85%

By Vandana Singh

December 15, 9:04 AM

Axcella Health Inc (NASDAQ:AXLA) announced organizational and program updates, including a reprioritization of its programs for Long COVID Fatigue and…

AXLA

Raymond James Downgrades Invitae to Market Perform

Related Posts

Arvinas Releases Early Cut Data Showing Encouraging Efficacy In Prostate Cancer With Certain Mutations

Equinor’s Massive Gas Pact: Long-Term Deal With Germany’s SEFE, Plus Hydrogen Partnership

Hess Midstream LP Announces Pricing Of $288M Secondary Public Offering Of 10M Class A Shares At A Price Of $28.80/Share

Axcella Therapeutics Puts Development Of NASH Program Aside, Reduces Workforce By 85%